 |
Allogeneic ex-vivo-expanded umbilical cord blood-derived hematopoietic CD34+ progenitor cells and allogeneic non-expanded umbilical cord blood-derived hematopoietic mature myeloid and lymphoid cells |
|---|---|
| Trade Name | |
| Orphan Indication | Treatment in haematopoietic stem cell transplantation |
| EU Market Approval | EU |
| EU Designation Date | 2017-03-20 00:00:00 |
| Sponsor | Regulatory Resources Group Ltd |
